Skip to main content

Table 2 Factors associated with pharmacist interventions

From: Development of clinical pharmacy services for intensive care units in Korea

 

OR (95% CI)a

P-value

Length of hospital stay, day

1.160 (1.134–1.186)

<0.001

Renal dysfunction

No

1

-

Yes

1.759 (1.340–2.309)

<0.001

Hepatic dysfunction

No

1

-

Yes

0.918 (0.639–1.318)

0.642

  1. OR, odds ratio; CI, confidence interval.
  2. aAdjusted for length of hospital stay, renal dysfunction, and hepatic dysfunction.